Amir Garakani, MD, DFAPA
Assistant Professor of Clinical Psychiatry; Chair, Psychiatry and Behavioral Health
Research & Publications
Biography
News
Coauthors
Selected Publications
- Commentary: Psychiatric Symptoms Related to Somatic IllnessGarakani A. Commentary: Psychiatric Symptoms Related to Somatic Illness Journal Of Psychiatric Practice 2022, 28: 514-515. PMID: 36355593, DOI: 10.1097/pra.0000000000000674.
- Gaming to relieve tension or anxiety and associations with health functioning, substance use and physical violence in high school studentsGarakani A, Zhai ZW, Hoff RA, Krishnan-Sarin S, Potenza MN. Gaming to relieve tension or anxiety and associations with health functioning, substance use and physical violence in high school students Journal Of Psychiatric Research 2021, 140: 461-467. PMID: 34147933, DOI: 10.1016/j.jpsychires.2021.05.055.
- Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical studyAmanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study BMC Neurology 2021, 21: 116. PMID: 33726699, PMCID: PMC7960879, DOI: 10.1186/s12883-021-02152-5.
- The Prevalence of Post-Traumatic Stress Disorder Related Symptoms in Coronavirus Outbreaks: A Systematic-Review and Meta-AnalysisSalehi M, Amanat M, Mohammadi M, Salmanian M, Rezaei N, Saghazadeh A, Garakani A. The Prevalence of Post-Traumatic Stress Disorder Related Symptoms in Coronavirus Outbreaks: A Systematic-Review and Meta-Analysis Journal Of Affective Disorders 2021, 282: 527-538. PMID: 33433382, PMCID: PMC7831964, DOI: 10.1016/j.jad.2020.12.188.
- Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment OptionsGarakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options Frontiers In Psychiatry 2020, 11: 595584. PMID: 33424664, PMCID: PMC7786299, DOI: 10.3389/fpsyt.2020.595584.
- Sublingual Oxytocin With Clozapine in a Patient With Persisting Psychotic Symptoms, Suicidal Thinking With Self-Harm.Garakani A, Buono FD, Marotta RF. Sublingual Oxytocin With Clozapine in a Patient With Persisting Psychotic Symptoms, Suicidal Thinking With Self-Harm. Journal Of Clinical Psychopharmacology 2020, 40: 507-509. PMID: 32701906, DOI: 10.1097/jcp.0000000000001248.
- T198. CAN AUGMENTED SUBLINGUAL OXYTOCIN DECREASE NEGATIVE SYMPTOMS WITHIN TREATMENT RESISTANT SCHIZOPHRENIC POPULATIONS: A PILOT STUDYMarotta R, Buono F, Garakani A, Rowe D. T198. CAN AUGMENTED SUBLINGUAL OXYTOCIN DECREASE NEGATIVE SYMPTOMS WITHIN TREATMENT RESISTANT SCHIZOPHRENIC POPULATIONS: A PILOT STUDY Schizophrenia Bulletin 2020, 46: s307-s307. PMCID: PMC7234300, DOI: 10.1093/schbul/sbaa029.758.
- Parsing the effects of comorbid adult ADHD and substance misuse on affective lability in bipolar disorderGarakani A, Buono FD, Larkin K, Goldberg JF. Parsing the effects of comorbid adult ADHD and substance misuse on affective lability in bipolar disorder Journal Of Affective Disorders 2020, 266: 338-340. PMID: 32056896, DOI: 10.1016/j.jad.2020.01.087.
- Why Physicians Die by Suicide: Lessons Learned From Their Families and Others Who CaredGarakani A. Why Physicians Die by Suicide: Lessons Learned From Their Families and Others Who Cared American Journal Of Psychiatry 2018, 175: 794-795. DOI: 10.1176/appi.ajp.2018.18040397.
- Personality DisordersEhrlich Y, Garakani A, Pavlos S, Siever L. Personality Disorders Family Medicine 2018 DOI: 10.2310/fm.1319.
- Personality DisordersEhrlich Y, Garakani A, Pavlos S, Siever L. Personality Disorders 2018 DOI: 10.2310/tywc.1319.
- Forensic PsychiatryAppel J, Garakani A, Kunz M. Forensic Psychiatry 2016, 368-372. DOI: 10.1002/9781118654231.ch43.
- Sleep‐Wake DisordersShenoy A, Fischer R, Garakani A. Sleep‐Wake Disorders 2016, 207-216. DOI: 10.1002/9781118654231.ch23.
- Neuropsychiatric aspects of concussionRadhakrishnan R, Garakani A, Gross LS, Goin MK, Pine J, Slaby AE, Sumner CR, Baron DA. Neuropsychiatric aspects of concussion The Lancet Psychiatry 2016, 3: 1166-1175. PMID: 27889010, DOI: 10.1016/s2215-0366(16)30266-8.
- Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literatureGarakani A, Jaffe RJ, Savla D, Welch AK, Protin CA, Bryson EO, McDowell DM. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature American Journal On Addictions 2016, 25: 358-369. PMID: 27037733, DOI: 10.1111/ajad.12372.
- Heart rate and respiratory response to doxapram in patients with panic disorderMartinez JM, Garakani A, Aaronson CJ, Gorman JM. Heart rate and respiratory response to doxapram in patients with panic disorder Psychiatry Research 2015, 227: 32-38. PMID: 25819170, PMCID: PMC4420657, DOI: 10.1016/j.psychres.2015.03.001.
- Schizotypal Personality DisorderGarakani A, Siever L. Schizotypal Personality Disorder 2015, 1-7. DOI: 10.1002/9781118625392.wbecp390.
- Personality DisordersEhrlich Y, Garakani A, Pavlos S, Siever L. Personality Disorders 2014 DOI: 10.2310/im.1319.
- Voluntary Psychiatric Hospitalization and Patient-Driven Requests for DischargeGarakani A, Shalenberg E, Burstin SC, Brendel R, Appel JM. Voluntary Psychiatric Hospitalization and Patient-Driven Requests for Discharge Harvard Review Of Psychiatry 2014, 22: 241-249. PMID: 24983871, DOI: 10.1097/hrp.0000000000000044.
- Advances in Psychopharmacology for Anxiety DisordersGarakani A, Murrough J, Iosifescu D. Advances in Psychopharmacology for Anxiety Disorders FOCUS The Journal Of Lifelong Learning In Psychiatry 2014, 12: 152-162. DOI: 10.1176/appi.focus.12.2.152.
- Iphis and Anaxarete in Ovid’s Metamorphoses: Poem of the Shut-Out LoverGarakani A, Mendelsohn N. Iphis and Anaxarete in Ovid’s Metamorphoses: Poem of the Shut-Out Lover American Journal Of Psychiatry 2013, 170: 721-722. PMID: 23820831, DOI: 10.1176/appi.ajp.2012.12101297.
- A 66-Year-Old Woman with Facial Tics and Social ImpairmentGarakani A, Welch A, Newcorn J. A 66-Year-Old Woman with Facial Tics and Social Impairment Psychiatric Annals 2013, 43: 10-14. DOI: 10.3928/00485713-20130109-03.
- Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.Goldberg JF, Garakani A, Ackerman SH. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse. The Journal Of Clinical Psychiatry 2012, 73: 1525-30. PMID: 23290325, DOI: 10.4088/jcp.12m07926.
- Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatmentGarakani A, Martinez JM, Yehuda R, Gorman JM. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment Journal Of Affective Disorders 2012, 146: 262-265. PMID: 22840611, DOI: 10.1016/j.jad.2012.06.037.
- PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSIONMartinez JM, Garakani A, Yehuda R, Gorman JM. PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION Depression And Anxiety 2011, 29: 32-38. PMID: 21898706, DOI: 10.1002/da.20876.
- The Neurobiology of Anxiety DisordersGarakani A, Murrough J, Charney D, Bremner J. The Neurobiology of Anxiety Disorders 2011, 655-690. DOI: 10.1093/med/9780199798261.003.0041.
- Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and AntagonistsKrystal JH, Mathew SJ, D’Souza D, Garakani A, Gunduz-Bruce H, Charney DS. Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists CNS Drugs 2010, 24: 669-693. PMID: 20658799, DOI: 10.2165/11533230-000000000-00000.
- The Pharmacological Treatment of Bipolar Disorder: The Question of Modern AdvancesHirschowitz J, Kolevzon A, Garakani A. The Pharmacological Treatment of Bipolar Disorder: The Question of Modern Advances Harvard Review Of Psychiatry 2010, 18: 266-278. PMID: 20825264, DOI: 10.3109/10673229.2010.507042.
- Heart Rate and Blood Pressure Changes During Autonomic Nervous System Challenge in Panic Disorder PatientsMartinez JM, Garakani A, Kaufmann H, Aaronson CJ, Gorman JM. Heart Rate and Blood Pressure Changes During Autonomic Nervous System Challenge in Panic Disorder Patients Psychosomatic Medicine 2010, 72: 442-449. PMID: 20368476, DOI: 10.1097/psy.0b013e3181d972c2.
- Neurobiology of Anxiety DisordersAmiel J, Mathew S, Garakani A, Neumeister A, Charney D. Neurobiology of Anxiety Disorders 2009 DOI: 10.1176/appi.books.9781585623860.as47.
- Anxiety Disorders: Neurochemical AspectsGarakani, A., Neumeister, A., Bonne, O., Charney, D.S. Anxiety Disorders: Neurochemical Aspects. In Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 9th edition, eds. B.J. Sadock, V.A. Sadock, P. Ruiz, Lippincott Williams & Wilkins, Philadelphia, PA, 2009, pp. 1871–1881.
- Review of: Kidnapping: An Investigator 's Guide to ProfilingGarakani A, Billick S. Review of: Kidnapping: An Investigator 's Guide to Profiling Journal Of Forensic Sciences 2008, 53: 1490-1490. DOI: 10.1111/j.1556-4029.2008.00891.x.
- Effect of medication and psychotherapy on heart rate variability in panic disorderGarakani A, Martinez JM, Aaronson CJ, Voustianiouk A, Kaufmann H, Gorman JM. Effect of medication and psychotherapy on heart rate variability in panic disorder Depression And Anxiety 2008, 26: 251-258. PMID: 18839407, DOI: 10.1002/da.20533.
- A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorderGarakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder International Clinical Psychopharmacology 2008, 23: 269-275. PMID: 18703936, DOI: 10.1097/yic.0b013e328301a74c.
- The Neurobiology of Anxiety DisordersGarakani A, Murrough J, Charney DS, Bremner, JD. The neurobiology of anxiety disorders. In Neurobiology of Mental Illness. 3rd edition, eds. D.S. Charney, E.J. Nestler EJ. Oxford University Press, USA, New York, NY, 2008. pp. 605–628.
- The effect of doxapram on brain imaging in patients with panic disorderGarakani A, Buchsbaum MS, Newmark RE, Goodman C, Aaronson CJ, Martinez JM, Torosjan Y, Chu KW, Gorman JM. The effect of doxapram on brain imaging in patients with panic disorder European Neuropsychopharmacology 2007, 17: 672-686. PMID: 17560768, PMCID: PMC2695988, DOI: 10.1016/j.euroneuro.2007.04.002.
- Neurobiology of anxiety disorders and implications for treatment.Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. Annals Of Global Health 2006, 73: 941-9. PMID: 17195879.
- General disaster psychiatryGarakani A, Hirschowitz J, Katz CL. General disaster psychiatry Psychiatric Clinics Of North America 2004, 27: 391-406. PMID: 15325484, DOI: 10.1016/j.psc.2004.03.002.
- Electrolyte-Balanced Sports Drink for Polydipsia-Hyponatremia in SchizophreniaQuitkin FM, Garakani A, Kelly KE. Electrolyte-Balanced Sports Drink for Polydipsia-Hyponatremia in Schizophrenia American Journal Of Psychiatry 2003, 160: 385-a-386. PMID: 12562594, DOI: 10.1176/appi.ajp.160.2.385-a.
- Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A ReviewGarakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review American Journal Of Therapeutics 2003, 10: 61-67. PMID: 12522523, DOI: 10.1097/00045391-200301000-00014.
- Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorderMarshall RD, Garakani A. Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder Psychiatric Clinics Of North America 2002, 25: 385-395. PMID: 12136506, DOI: 10.1016/s0193-953x(01)00005-3.